Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maud Condomines

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cell Stem Cell|August 6, 2011
Tolerance induction by allogeneic hematopoietic stem cellsMaud Condomines, Michel Sadelain
Nature Biotechnology|December 18, 2012
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cellsChristopher C Kloss, Maud Condomines, Marc Cartellieri, et al.
Plos One|June 26, 2015
Tumor-Targeted Human T Cells Expressing CD28-Based Chimeric Antigen Receptors Circumvent CTLA-4 InhibitionMaud Condomines, Jon Arnason, Reuben Benjamin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myelomaMaud Condomines, Dirk Hose, Thierry Rème, et al.
Experimental Hematology|February 21, 2007
B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitroZhao-Yang Lu, Maud Condomines, Karin Tarte, et al.
Cancer Cell|October 14, 2015
Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T CellsZeguo Zhao, Maud Condomines, Sjoukje J C van der Stegen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 8, 2009
Increased plasma-immune cytokines throughout the high-dose melphalan-induced lymphodepletion in patients with multiple myeloma: a window for adoptive immunotherapyMaud Condomines, Jean-Luc Veyrune, Marion Larroque, et al.
British Journal of Haematology|September 28, 2007
In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myelomaMaka Burjanadzé, Maud Condomines, Thierry Reme, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factorMaud Condomines, Philippe Quittet, Zhao-Yang Lu, et al.
Experimental Hematology|March 30, 2006
Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myelomaMichael Hundemer, Stefanie Schmidt, Maud Condomines, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cell Stem Cell|August 6, 2011
Tolerance induction by allogeneic hematopoietic stem cellsMaud Condomines, Michel Sadelain
Nature Biotechnology|December 18, 2012
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cellsChristopher C Kloss, Maud Condomines, Marc Cartellieri, et al.
Plos One|June 26, 2015
Tumor-Targeted Human T Cells Expressing CD28-Based Chimeric Antigen Receptors Circumvent CTLA-4 InhibitionMaud Condomines, Jon Arnason, Reuben Benjamin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myelomaMaud Condomines, Dirk Hose, Thierry Rème, et al.
Experimental Hematology|February 21, 2007
B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitroZhao-Yang Lu, Maud Condomines, Karin Tarte, et al.
Cancer Cell|October 14, 2015
Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T CellsZeguo Zhao, Maud Condomines, Sjoukje J C van der Stegen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 8, 2009
Increased plasma-immune cytokines throughout the high-dose melphalan-induced lymphodepletion in patients with multiple myeloma: a window for adoptive immunotherapyMaud Condomines, Jean-Luc Veyrune, Marion Larroque, et al.
British Journal of Haematology|September 28, 2007
In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myelomaMaka Burjanadzé, Maud Condomines, Thierry Reme, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factorMaud Condomines, Philippe Quittet, Zhao-Yang Lu, et al.
Experimental Hematology|March 30, 2006
Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myelomaMichael Hundemer, Stefanie Schmidt, Maud Condomines, et al.
Pageof 2